Through the Inherited Metabolic Diseases (IMD) Program, the Ministry of Health and Long-Term Care covers the full cost of certain outpatient drugs, supplements and specialty foods used in the treatment of specific inherited metabolic disorders. The IMD Program covers:

• Specific drugs and supplements
• Modified L-Amino Acid mixtures (“medical foods”)
• Special Low Protein Foods
• Other supplements
• Infant Feeds
• Complete Enteral Feeds

The IMD Program will cover the costs of the foregoing types of products (“Funded Products”), provided that the patient :

• Is an Ontario resident with valid Ontario Health Insurance (OHIP); 
• Has been diagnosed with an inherited metabolic disorder for which one of the Funded Products has been prescribed as a treatment;
• Is under the care of a physician from a designated treatment centre;
• Obtains the Funded Products from a designated treatment centre.

To register a patient in the IMD Program, an application and consent form must be completed and submitted to the ministry.

Drugs For Rare Diseases (DRD)

For information on the ministry’s Drug for Rare Diseases (DRD) framework, please refer to Drugs For Rare Diseases (DRD) section.

Effective October 1, 2011, the administration and funding of laronidase was transitioned from the University Health Network (UHN) to the IMD program.  All current and new patients will be enrolled in the IMD program. Patients must meet the funding criteria as outlined in the reimbursement guidelines:

• Reimbursement Guidelines
• Request Form

Inquiries regarding the IMD Program should be directed to :

Ontario Public Drug Programs
5700 Yonge Street, 3^rd Floor
Toronto ON  M2M 4K5
Tel.:416-327-8109
Fax: 416-327-8123
Email: PublicDrugPrgrms.moh@ontario.ca